TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】Cash flow
Market cap
P/E ratio
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Depreciation & amortization | 10,951 | 11,042 | 11,561 | 11,117 | 10,423 | 10,154 | 10,073 | 11,366 | 14,700 | 15,379 | 16,398 |
| Cash from operations | 41,292 | 60,233 | 33,714 | 43,058 | 40,066 | 39,852 | 19,222 | 41,992 | 42,026 | 28,506 | 40,972 |
| Capital expenditures | -11,285 | -9,820 | -5,264 | -6,923 | -7,322 | -2,726 | -3,434 | -5,456 | -10,251 | -10,040 | -26,433 |
| Cash from investing | -9,359 | -21,998 | -18,162 | -11,662 | -1,361 | -19,908 | 66,044 | -107,081 | -1,958 | -7,063 | -27,130 |
| Payments for dividends | -8,858 | -8,894 | -8,900 | -8,903 | -7,974 | -8,771 | -8,773 | -9,586 | -8,787 | -7,415 | -8,206 |
| Repurchases of common stock | -61 | -110 | -97 | -10,097 | -100 | -96 | -125 | -48 | -41 | -43 | -34 |
| Repayments of term debt | -154 | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | -10,064 | -9,439 | -9,443 | -19,525 | -8,404 | -9,867 | -15,467 | -11,696 | -11,346 | -10,057 | -10,877 |